AKBA
Akebia Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.33 / 10
Underperform
AKBA's fundamental framework scores only 2.3/10, indicating significant challenges. Key weaknesses include low Profit-MV (-0.8996) and Net profit / Total profit (%) (91.8153, but scored 0 due to group 1), while Asset-MV (-0.5007) and Revenue-MV (-0.5817) also underperform. Gross profit margin is high at 84.9211, but this is offset by poor asset turnover and profitability metrics. Historical back-tests show modest returns (1-3%) with moderate confidence, reinforcing a cautious stance.
Analysis Checks(6/10)
Revenue-MV
Value-0.58
Score1/3
Weight12.72%
1M Return5.20%
Value-0.58
Score1/3
Weight12.72%
1M Return5.20%
Gross profit margin (%)
Value84.92
Score2/3
Weight3.15%
1M Return1.47%
Value84.92
Score2/3
Weight3.15%
1M Return1.47%
PB-ROE
Value0.91
Score0/3
Weight8.69%
1M Return3.56%
Value0.91
Score0/3
Weight8.69%
1M Return3.56%
Fixed assets turnover ratio
Value97.24
Score2/3
Weight0.25%
1M Return0.12%
Value97.24
Score2/3
Weight0.25%
1M Return0.12%
Cash-MV
Value0.13
Score2/3
Weight19.07%
1M Return7.73%
Value0.13
Score2/3
Weight19.07%
1M Return7.73%
Inventory turnover ratio
Value1.54
Score2/3
Weight-4.83%
1M Return-2.63%
Value1.54
Score2/3
Weight-4.83%
1M Return-2.63%
Profit-MV
Value-0.90
Score2/3
Weight19.04%
1M Return7.79%
Value-0.90
Score2/3
Weight19.04%
1M Return7.79%
Current assets turnover ratio
Value0.96
Score1/3
Weight-0.96%
1M Return-0.48%
Value0.96
Score1/3
Weight-0.96%
1M Return-0.48%
Asset-MV
Value-0.50
Score2/3
Weight43.44%
1M Return15.13%
Value-0.50
Score2/3
Weight43.44%
1M Return15.13%
Net profit / Total profit (%)
Value91.82
Score0/3
Weight-0.56%
1M Return-0.30%
Value91.82
Score0/3
Weight-0.56%
1M Return-0.30%
Revenue-MV
Value-0.58
Score1/3
Weight12.72%
1M Return5.20%
Value-0.58
Score1/3
Weight12.72%
1M Return5.20%
Inventory turnover ratio
Value1.54
Score2/3
Weight-4.83%
1M Return-2.63%
Value1.54
Score2/3
Weight-4.83%
1M Return-2.63%
Gross profit margin (%)
Value84.92
Score2/3
Weight3.15%
1M Return1.47%
Value84.92
Score2/3
Weight3.15%
1M Return1.47%
Profit-MV
Value-0.90
Score2/3
Weight19.04%
1M Return7.79%
Value-0.90
Score2/3
Weight19.04%
1M Return7.79%
PB-ROE
Value0.91
Score0/3
Weight8.69%
1M Return3.56%
Value0.91
Score0/3
Weight8.69%
1M Return3.56%
Current assets turnover ratio
Value0.96
Score1/3
Weight-0.96%
1M Return-0.48%
Value0.96
Score1/3
Weight-0.96%
1M Return-0.48%
Fixed assets turnover ratio
Value97.24
Score2/3
Weight0.25%
1M Return0.12%
Value97.24
Score2/3
Weight0.25%
1M Return0.12%
Asset-MV
Value-0.50
Score2/3
Weight43.44%
1M Return15.13%
Value-0.50
Score2/3
Weight43.44%
1M Return15.13%
Cash-MV
Value0.13
Score2/3
Weight19.07%
1M Return7.73%
Value0.13
Score2/3
Weight19.07%
1M Return7.73%
Net profit / Total profit (%)
Value91.82
Score0/3
Weight-0.56%
1M Return-0.30%
Value91.82
Score0/3
Weight-0.56%
1M Return-0.30%
Is AKBA undervalued or overvalued?
- AKBA scores 2.33/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -7.07% net margin, -23.19 P/E ratio, 8.87 P/B ratio, and 63.64% earnings growth, these metrics solidify its Underperform investment rating.
